Specific mutation screening of TP53 gene by low-density DNA microarray

被引:0
|
作者
Rangel-Lopez, Angelica [1 ,2 ,3 ]
Mendez-Tenorio, Alfonso [3 ]
Beattie, Kenneth L. [4 ]
Maldonado, Rogelio [3 ]
Mendoza, Patricia [1 ]
Vazquez, Guelaguetza [1 ]
Perez-Plasencia, Carlos [5 ]
Sanchez, Martha [2 ]
Navarro, Guillermo [6 ]
Salcedo, Mauricio [1 ]
机构
[1] Hosp Oncol, Lab Oncol Genom, Unidad Invest Med Enfermedades Oncol, CMN Siglo XXI IMSS, Mexico City, DF, Mexico
[2] Hosp Especialidades Ctr Med La Raza, CMN Siglo XXI IMSS, Unidad Invest Med Enfermedades Nefrol, Mexico City, DF, Mexico
[3] Escuela Nacl Ciencias Biol, Lab Biotecnol & Bioinformat Genom, Ipn Mexico City, Mexico
[4] Amerigenics Inc, Crossville, TN USA
[5] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City, DF, Mexico
[6] Univ Nacl Autonoma Mexico, Lab Organomet, Mexico City, DF, Mexico
关键词
oligonucleotide microarray; TP53; gene; point mutations;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
TP53 is the most commonly mutated gene in human cancers. Approximately 90% of mutations in this gene are localized between domains encoding exons 5 to 8. The aim of this investigation was to examine the ability of the low density DNA microarray with the assistance of double tandem hybridization platform to characterize TP53 mutational hotspots in exons 5, 7, and 8 of the TP53. Nineteen capture probes specific to each potential mutation site were designed to hybridize to specific site. Virtual hybridization was used to predict the stability of hybridization of each capture probe with the target. Thirty-three DNA samples from different sources were analyzed for mutants in these exons. A total of 32 codon substitutions were found by DNA sequencing. 24 of them a showed a perfect correlation with the hybridization pattern system and DNA sequencing analysis of the regions scanned. Although in this work we directed our attention to some of the most representative mutations of the TP53 gene, the results suggest that this microarray system proved to be a rapid, reliable, and effective method for screening all the mutations in TP53 gene.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [31] TP53 gene mutations in plasma DNA of cancer patients
    Silva, JM
    Gonzalez, R
    Dominguez, G
    Garcia, JM
    España, P
    Bonilla, F
    GENES CHROMOSOMES & CANCER, 1999, 24 (02): : 160 - 161
  • [32] TP53 gene in blood plasma DNA of tumor patients
    Schlechte, HH
    Stelzer, C
    Weickmann, S
    Fleischhacker, M
    Schulze, G
    CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 : 61 - 69
  • [33] Surgical Treatment of Craniofacial Fibrous Dysplasia With TP53 Gene Mutation
    Chen, Lang
    Chen, Yujing
    Xiao, Kai
    Hu, Fei
    Wang, Huanming
    Shao, Qiang
    JOURNAL OF CRANIOFACIAL SURGERY, 2024, 35 (02) : 608 - 610
  • [34] Bioinformatic Identification of TP53 Gene Mutation Hotspots in Colorectal Cancer
    Kovacs, Zsolt
    Sugimura, Haruhiko
    Gyorgy, Tamas Attila
    Osvath, Eva
    Manirakiza, Felix
    Gurzu, Simona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [35] Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation
    Schneider, BG
    John-Aryankalayil, M
    Rowsey, JJ
    Dushku, N
    Reid, TW
    EXPERIMENTAL EYE RESEARCH, 2006, 82 (01) : 91 - 98
  • [36] Focus on the p53 gene and cancer:: Advances in TP53 mutation research
    Soussi, T
    HUMAN MUTATION, 2003, 21 (03) : 173 - 175
  • [37] The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density
    Dane Cheasley
    Lisa Devereux
    Siobhan Hughes
    Carolyn Nickson
    Pietro Procopio
    Grant Lee
    Na Li
    Vicki Pridmore
    Kenneth Elder
    G. Bruce Mann
    Tanjina Kader
    Simone M. Rowley
    Stephen B. Fox
    David Byrne
    Hugo Saunders
    Kenji M. Fujihara
    Belle Lim
    Kylie L. Gorringe
    Ian G. Campbell
    npj Breast Cancer, 6
  • [38] The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density
    Cheasley, Dane
    Devereux, Lisa
    Hughes, Siobhan
    Nickson, Carolyn
    Procopio, Pietro
    Lee, Grant
    Li, Na
    Pridmore, Vicki
    Elder, Kenneth
    Mann, G. Bruce
    Kader, Tanjina
    Rowley, Simone M.
    Fox, Stephen B.
    Byrne, David
    Saunders, Hugo
    Fujihara, Kenji M.
    Lim, Belle
    Gorringe, Kylie L.
    Campbell, Ian G.
    NPJ BREAST CANCER, 2020, 6 (01)
  • [39] Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis
    Wen, WH
    Bernstein, L
    Lescallett, J
    Beazer-Barclay, Y
    Sullivan-Halley, J
    White, M
    Press, MF
    CANCER RESEARCH, 2000, 60 (10) : 2716 - 2722
  • [40] EGFR gene amplification and TP53 mutation gene expression profiles in glioblastomas.
    Louis, DN
    Pomeroy, SL
    Golub, TR
    Nutt, CL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (05): : 542 - 542